ENTA logo

Enanta Pharmaceuticals (ENTA) CAPEX

Annual CAPEX

$17.95 M
+$8.89 M+98.15%

September 30, 2024

Summary

Performance

1-Year Change

+98.15%

3-Year Change

+2293.07%

5-Year Change

+231.33%

15-Year Change

+616.2%

ENTA CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.86%
ENTA annual capital expenditures is higher than 72.86% of companies in Healthcare sector

High & Low

All-time High

$17.95 M
ENTA annual capital expenditures is currently at an all-time high

3-Year Low

$750.00 K
ENTA annual capital expenditures is currently +2293.07% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
ENTA previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
ENTA next annual earnings announcement has not yet been scheduled

OtherENTAcash flowmetrics:

Annual FCF

-$96.71 M
ENTA annual free cash flow is -$96.71 million

Annual CFO

-$78.76 M
ENTA annual cash flow from operations is -$78.76 million

Annual CFI

$58.23 M
ENTA annual cash flow from investing activities is $58.23 million

Annual CFF

-$27.63 M
ENTA annual cash flow from financing activities is -$27.63 million

Quarterly CAPEX

$8.74 M
-$206.00 K-2.30%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

ENTA Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.42%
ENTA quarterly capital expenditures is higher than 77.42% of companies in Healthcare sector

High & Low

All-time High

$8.95 M
ENTA quarterly capital expenditures is currently -2.30% below its historical high of $8.95 million

3-Year Low

$74.00 K
ENTA quarterly capital expenditures is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ENTA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 6, 2025
ENTA next earnings announcement is scheduled for May 6, 2025

OtherENTAcash flowmetrics:

Quarterly FCF

-$25.55 M
ENTA quarterly free cash flow is -$25.55 million

Quarterly CFO

-$16.80 M
ENTA quarterly cash flow from operations is -$16.80 million

Quarterly CFI

$68.90 M
ENTA quarterly cash flow from investing activities is $68.90 million

Quarterly CFF

-$4.99 M
ENTA quarterly cash flow from financing activities is -$4.99 million

TTM CAPEX

$25.91 M
+$7.96 M+44.34%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

ENTA TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.87%
ENTA TTM capital expenditures is higher than 72.87% of companies in Healthcare sector

High & Low

All-time High

$25.91 M
ENTA TTM capital expenditures is currently at an all-time high

3-Year Low

$721.00 K
ENTA TTM capital expenditures is currently +3493.07% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ENTA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 6, 2025
ENTA next earnings announcement is scheduled for May 6, 2025

OtherENTAcash flowmetrics:

TTM FCF

-$96.48 M
ENTA TTM free cash flow is -$96.48 million

TTM CFO

-$70.58 M
ENTA TTM cash flow from operations is -$70.58 million

TTM CFI

$140.25 M
ENTA TTM cash flow from investing activities is $140.25 million

TTM CFF

-$25.26 M
ENTA TTM cash flow from financing activities is -$25.26 million

ENTA CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+98.2%0.0%0.0%
3 y3 years+2293.1%0.0%0.0%
5 y5 years+231.3%0.0%0.0%

ENTA CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+2293.1%-2.3%>+9999.0%at high+3493.1%
5 y5-yearat high+2293.1%-2.3%>+9999.0%at high+3493.1%
alltimeall timeat high>+9999.0%-2.3%>+9999.0%at high>+9999.0%

Enanta Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
-
$8.74 M(-2.3%)
$25.91 M(+44.3%)
Sep 2024
$17.95 M(+98.1%)
$8.95 M(+36.8%)
$17.95 M(+73.2%)
Jun 2024
-
$6.54 M(+292.2%)
$10.37 M(+73.5%)
Mar 2024
-
$1.67 M(+111.9%)
$5.97 M(-10.7%)
Dec 2023
-
$787.00 K(-42.5%)
$6.69 M(-26.2%)
Sep 2023
$9.06 M(+326.3%)
$1.37 M(-36.4%)
$9.06 M(-0.8%)
Jun 2023
-
$2.15 M(-9.7%)
$9.13 M(+26.3%)
Mar 2023
-
$2.38 M(-24.5%)
$7.23 M(+46.9%)
Dec 2022
-
$3.16 M(+119.6%)
$4.92 M(+131.4%)
Sep 2022
$2.13 M(+183.3%)
$1.44 M(+472.5%)
$2.13 M(+194.7%)
Jun 2022
-
$251.00 K(+239.2%)
$721.00 K(-17.0%)
Mar 2022
-
$74.00 K(-79.6%)
$869.00 K(-6.1%)
Dec 2021
-
$363.00 K(+1000.0%)
$925.00 K(+23.3%)
Sep 2021
$750.00 K(-48.1%)
$33.00 K(-91.7%)
$750.00 K(-28.4%)
Jun 2021
-
$399.00 K(+206.9%)
$1.05 M(+13.7%)
Mar 2021
-
$130.00 K(-30.9%)
$921.00 K(-19.6%)
Dec 2020
-
$188.00 K(-43.0%)
$1.15 M(-20.8%)
Sep 2020
$1.45 M(-73.3%)
$330.00 K(+20.9%)
$1.45 M(+2.4%)
Jun 2020
-
$273.00 K(-22.9%)
$1.41 M(-58.1%)
Mar 2020
-
$354.00 K(-27.5%)
$3.37 M(-39.0%)
Dec 2019
-
$488.00 K(+64.9%)
$5.52 M(+1.9%)
Sep 2019
$5.42 M(+81.7%)
$296.00 K(-86.7%)
$5.42 M(-5.7%)
Jun 2019
-
$2.23 M(-11.0%)
$5.74 M(+24.4%)
Mar 2019
-
$2.51 M(+552.9%)
$4.62 M(+61.3%)
Dec 2018
-
$384.00 K(-38.4%)
$2.86 M(-4.0%)
Sep 2018
$2.98 M
$623.00 K(-43.5%)
$2.98 M(+15.0%)
Jun 2018
-
$1.10 M(+46.5%)
$2.59 M(+16.2%)
DateAnnualQuarterlyTTM
Mar 2018
-
$752.00 K(+49.2%)
$2.23 M(+8.5%)
Dec 2017
-
$504.00 K(+115.4%)
$2.06 M(-17.9%)
Sep 2017
$2.51 M(-47.1%)
$234.00 K(-68.4%)
$2.51 M(-6.7%)
Jun 2017
-
$741.00 K(+28.2%)
$2.69 M(+5.0%)
Mar 2017
-
$578.00 K(-39.3%)
$2.56 M(-26.8%)
Dec 2016
-
$953.00 K(+129.6%)
$3.49 M(-26.3%)
Sep 2016
$4.74 M(+102.8%)
$415.00 K(-32.3%)
$4.74 M(-19.7%)
Jun 2016
-
$613.00 K(-59.5%)
$5.90 M(+3.7%)
Mar 2016
-
$1.51 M(-31.1%)
$5.69 M(+33.0%)
Dec 2015
-
$2.20 M(+39.1%)
$4.28 M(+83.1%)
Sep 2015
$2.34 M(+127.2%)
$1.58 M(+295.0%)
$2.34 M(+88.2%)
Jun 2015
-
$400.00 K(+300.0%)
$1.24 M(+1.8%)
Mar 2015
-
$100.00 K(-60.9%)
$1.22 M(-3.3%)
Dec 2014
-
$256.00 K(-47.2%)
$1.26 M(+22.6%)
Sep 2014
$1.03 M(+69.6%)
$485.00 K(+28.3%)
$1.03 M(+38.0%)
Jun 2014
-
$378.00 K(+168.1%)
$745.00 K(+77.8%)
Mar 2014
-
$141.00 K(+487.5%)
$419.00 K(-32.3%)
Dec 2013
-
$24.00 K(-88.1%)
$619.00 K(+2.1%)
Sep 2013
$606.00 K(+140.5%)
$202.00 K(+288.5%)
$606.00 K(+17.7%)
Jun 2013
-
$52.00 K(-84.8%)
$515.00 K(+1.0%)
Mar 2013
-
$341.00 K(+3000.0%)
$510.00 K(+117.0%)
Dec 2012
-
$11.00 K(-90.1%)
$235.00 K(-6.7%)
Sep 2012
$252.00 K(-43.4%)
$111.00 K(+136.2%)
$252.00 K(+78.7%)
Jun 2012
-
$47.00 K(-28.8%)
$141.00 K(+50.0%)
Mar 2012
-
$66.00 K(+135.7%)
$94.00 K(+235.7%)
Dec 2011
-
$28.00 K
$28.00 K
Sep 2011
$445.00 K(+1102.7%)
-
-
Sep 2010
$37.00 K
-
-

FAQ

  • What is Enanta Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals annual CAPEX year-on-year change?
  • What is Enanta Pharmaceuticals quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly CAPEX year-on-year change?
  • What is Enanta Pharmaceuticals TTM capital expenditures?
  • What is the all time high TTM CAPEX for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals TTM CAPEX year-on-year change?

What is Enanta Pharmaceuticals annual capital expenditures?

The current annual CAPEX of ENTA is $17.95 M

What is the all time high annual CAPEX for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high annual capital expenditures is $17.95 M

What is Enanta Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, ENTA annual capital expenditures has changed by +$8.89 M (+98.15%)

What is Enanta Pharmaceuticals quarterly capital expenditures?

The current quarterly CAPEX of ENTA is $8.74 M

What is the all time high quarterly CAPEX for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high quarterly capital expenditures is $8.95 M

What is Enanta Pharmaceuticals quarterly CAPEX year-on-year change?

Over the past year, ENTA quarterly capital expenditures has changed by $0.00 (0.00%)

What is Enanta Pharmaceuticals TTM capital expenditures?

The current TTM CAPEX of ENTA is $25.91 M

What is the all time high TTM CAPEX for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high TTM capital expenditures is $25.91 M

What is Enanta Pharmaceuticals TTM CAPEX year-on-year change?

Over the past year, ENTA TTM capital expenditures has changed by $0.00 (0.00%)